We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayshore Announces FDA Approval of First ANDA
Bayshore Announces FDA Approval of First ANDA
September 28, 2012
Bayshore Pharmaceuticals has announced that the FDA has granted final approval for their ANDA for Methscopolamine Bromide tablets (2.5 & 5 mg tablets). PRWeb
